Episode 347: #81-1: Neurodevelopment & CHD: Risk Stratification and Challenges

In this week's episode, host Paul Wirkus, MD, FAAP, and guests Kristi Glotzbach, MD, and Laura Wood, PhD discuss recommendations for recognizing and addressing neurodevelopmental risks in infants and children with congenital heart disease (CHD). Listen in as they review strategies for risk identification, protection, screening, and evaluation, and focus on how clinicians can stratify risk for neurodevelopmental challenges in this vulnerable population. Have a question? Email [email protected]. Your questions will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.